{
    "success": true,
    "data": {
        "id": 1669102,
        "msgid": "bmri-buyback-plan-retail-investors-should-heed-analyst-recommendations-1775803857",
        "date": "2026-04-10 12:44:00",
        "title": "BMRI Buyback Plan: Retail Investors Should Heed Analyst Recommendations",
        "author": "Erlangga Djumena",
        "source": "KOMPAS",
        "tags": "",
        "topic": "Finance",
        "summary": "PT Bank Mandiri (Persero) Tbk (BMRI) is planning a share buyback valued at Rp 1.7 trillion, which analysts view as a positive short-term catalyst for the stock price, potentially boosting market sentiment and limiting downside risks without significantly altering free float or foreign investor interest due to the bank's strong liquidity. However, experts caution retail investors against excessive euphoria, emphasising that the buyback does not address long-term fundamentals and recommend entering positions at undervalued levels or using it for short-term trading rather than chasing market hype. This move signals management's confidence in the current valuation but represents only 0.398% of the company's market capitalisation, minimising its structural impact on the market.",
        "content": "<p>JAKARTA, KOMPAS.com - The planned share buyback by PT Bank Mandiri\n(Persero) Tbk (BMRI) is considered capable of serving as a positive\ncatalyst for short-term stock price movements. However, investors are\nreminded not to get carried away by excessive euphoria, as this\ncorporate action is not a determinant of long-term fundamental\ndirection. Capital market observer Reydi Octa views the buyback step as\nreflecting management\u2019s confidence that the current stock valuation is\nat an attractive level for accumulation. This sentiment often acts as a\npsychological driver in the market, particularly in holding back selling\npressure and triggering potential stock price rebounds. Technically, the\nbuyback action has the potential to reduce the portion of public shares\n(free float) circulating in the market. However, for a large-cap issuer\nlike BMRI, the reduction in free float is believed not to disrupt\nforeign investor interest. According to him, BMRI\u2019s very strong stock\nliquidity and its position as one of the main portfolio holdings for\nglobal funds make the risk of declining foreign interest relatively\nsmall, as long as the ownership structure does not change extremely.\n\u201cIndeed, technically, a buyback can reduce free float. Nevertheless, for\na large stock like BMRI, the impact on declining foreign interest is not\nsignificant because its liquidity remains very strong and it is part of\nthe main portfolio for global funds,\u201d he explained. Furthermore, Reydi\nemphasised that the buyback is not a fundamental factor capable of\nsustainably lifting the stock price. Its effect is more short-term in\nnature and does not always reflect improved company performance.\nTherefore, retail investors are advised to remain rational in making\ndecisions. \u201cFrom a price perspective, the buyback tends to be a\nshort-term positive catalyst, holding downside, triggering rebounds but\nnot a long-term fundamental factor. For retail investors, the key is not\nto FOMO,\u201d he said. He added that a wiser strategy is to enter when the\nvaluation is still undervalued before sentiment strengthens, or to\nutilise the buyback momentum for short-term trading, rather than chasing\nprices amid market euphoria. \u201cA wiser strategy is to enter when the\nvaluation is still cheap before euphoria, or to utilise the momentum for\nshort-term trading,\u201d Reydi stressed. In agreement, Investment Specialist\nat PT Korea Investment and Sekuritas Indonesia (KISI), Azharys Hardian,\nstated that BMRI\u2019s share buyback plan worth Rp 1.7 trillion will not\nhave a significant impact on market structure. This value is relatively\nsmall because it is equivalent to only about 0.398 percent of the\ncompany\u2019s total market capitalisation, thus not large enough to\nmaterially affect the balance of share supply and demand. \u201cBMRI\u2019s\nbuyback plan worth Rp 1.7 trillion has a minimal impact on market\nstructure because it only represents about 0.398 percent of the total\nmarket capitalisation,\u201d Azharys said when contacted by Kompas.com on\nThursday night (9\/4\/2026). Regarding whether the buyback will drive up\nBMRI\u2019s stock price, Azharys assessed that this corporate action\nfunctions more as a company strategy to manage capital structure and\nprovide a confidence signal regarding stock valuation, rather than as a\nfactor capable of aggressively moving prices in the market. \u201cThis\ncorporate action functions more as a signal of management\u2019s confidence\nin the company\u2019s valuation rather than a significant price driver,\u201d he\ncontinued.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/bmri-buyback-plan-retail-investors-should-heed-analyst-recommendations-1775803857",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}